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Previous studies have shown that interleukin-1 (IL-l) is 
present in normal human epidermis. H owever, with immu-
nohistochemical techniques, epidermal IL-l immunoreac-
tivity has been found in only a limited number of epidermal 
cells. ln the present study, we show that both I L-1 alpha and 
beta immunoreactivities can be detected in all epidermal cell 
layers, provided optimal processing of tissue samples is used. 
The usc of isolated epidermal cells showed that keratinocytes 
at variom stages of maturation display both membrane-asso-
ciated and cytosolic IL- l alpha and beta immunoreactivities. 
Secreted human inrerleukin- 1 (IL-l ) is a 17-kD polypep-ude of two major forms with pi: sat pH 5 (IL- l alpha) and 7 (IL- l beta). Both forms have intracellular precursors of 31 kD [I ,2]. Additionally, activated human monocytes express a membrane-associated IL- 1 of 23 kD which 
reacts with antibodies to IL- l alpha, bur not to IL-l beta [3,4). 
Although the two major fonm ofiL- 1 show only limited homology 
in the1r amino acid sequence, their various functions seem to be 
identical, and they share the same receptor [2]. 
Epidermal IL-l was originally defined as an epidermal cell-de-
rived thymocyte-activaung factor [ET AF] (5,6 ]. Recent studies have 
shown that both normal and diseased human epidermis contain 
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ABC: avidin-biou n complex 
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BSA: bovmc serum albumm 
DAB: d1ammobcnz1dmc tcrrahydrochloride 
FITC: fluorescein 1sotluocyanate 
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LPS: hpopol}•sacchandc 
MoAb: monoclonal Jnubody 
mRNA: messenger RNA 
n: natural (from human monocyte) 
PAP: peroxidase anti-peroxidase 
PBS: phosphate-buffered saline 
pi: 1soelccmc pomt 
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After protease trearmenr of tissue sections, the IL-l beta im-
munoreactivity of the granular cell layer was enhanced by 
some antibodies used, whereas in the other cell layers it was 
clearly lower. We a) suggest a different cellular localization, 
processing, and/or binding to subcellular structures of IL- l 
during the differentiation process of human keratinocytes 
and b) outline the technical difficulties in any immunohisto-
logic approach to IL-1 status in diseased skin.] Invest Dermatol 
95:31-38, 1990 
bioactive I L- 1 (7 ,8 ]. Fractionation of various epidermal cel l layers of 
normal human epidermt~ with subsequent bioassay of IL-l activity 
ha~ suggested that approximately half the activity is lost after strip-
ping the stratum corneum [7]. Membrane-associated IL-1 acu vity in 
kerarinocytes has been detected recently (9]; however, chis activity 
was repo rted to be only a fraction of the cytosolic IL- 1 activity [tO]. 
Previous immunohistochemical swdies have shown intercellular 
or membrane-associated staining in some cells of normal [ 11,12] 
and diseased (13] human epidermis. There is, however, variation in 
the distribution of IL- l immunoreactive cel ls reported in different 
studies. Such discrepancies may be due to differential exposure of 
epttopes, as previously discussed [12). This tssue is particularly im-
portant, because the processing of the IL-1 molecule throughout the 
differentiation process of the keratinocytes may bt> of major biologic 
importance. We have reconsidered this issue by using three differ-
ent approaches: a) optimizing immunohistochemical methods, b) 
S[Udying IL- l immunoreacuvity in isolated epidermal cells to avoid 
intercellular staining, and c) using enzymatic treatment of the tis-
sues and cells. 
MATERIALS AND METHODS 
Skin Biopsies and Tissue Processing Skin biopsies were taken 
from healthy volunteer~ on the volar side of the forearm (35 biop-
sies), the back (12 biopsies), and the palm of the hand (7 biopsies}. 
Some of the tissues were snap-frozen in liquid isopentane at - 50"C 
and stored ac - 70"C for further processing. For cryostat sectionmg 
of ttssues, samples were embedded in Tissue-Tek O .C.T . Com-
pound (Miles Laboratories, Elkhart, IN) at -24"C. Cryostat sec-
uons were either further processed without fixation or were fixed in 
acetone at -20"C for 10 min, in 1.5% aqueous glutaraldehyde at 
+ 4 •c (10 min), in 4% paraformaldehyde at +4"C (10 min}, in 4% 
formaldehyde at +20"C (5 min) or in Bouin's fluid at+ 20"C (15 
sec). For paraffin sections, biopsies were fixed in either Bouin's 
flu1d, 1.5% aqueous glutaraldehyde, 4% neutral formaldehyde, or 
4% para formaldehyde for various periods of time. 
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Preparation oflsolated Epidermal Cells Suction bhsters were 
obtained from the abdominal skin of 10 healthy volunteers using 
the technique developed by Kiistala and Mustakalho [ 14). The roofs 
of the bli;ters were removed with sctssors and a parr of tweezers and 
nnsed in Dulbecco's calcium- and magnestum-free phosphate-buf-
fered saline (PBS: Gibco, Paisley, Scotland) containmg 100 IU /ml 
pcmctlhn, 100 ,ug/ml streptomycin, and 0.25 ,ug/ml amphotencm 
B. Tht' blister roofs were then transferred to Dulbccco's PBS sup-
plemenred with 0.25% trypsm (T -8253, Stgma, St. Louis, MO). 
Aftt'r a 30-mm incubation at 37" C, the b!tster roofs were transferred 
into a test rube containing Dulbecco's PBS supplemented with 10% 
human All serum. After gentle agitation, the blister roofs were 
separated by centrifuging. The pellet was harvested, and the stratum 
corneum and the supernatant fluid were discarded. The epidermal 
cells were resuspended in medium, after which cytospin prepara-
tions were made using a Shandon Elliot cytocenrrifuge at 80 rpm 
for 5 min. The preparations were fixed immedtately at+ 2o•c in 
4% paraformaldehydc for 2 mtn, acetone for 10 mm, or ether for 1 
min, or were left unfixed. The glass slides were subsequently rinsed 
in PBS. 
Enzymatic Treatment of Tissues and Cells Isolated unfixed 
eptdcrmal cells and cryostat sections fixed m paraformaldehyde 
were placed in PBS containing 0.001% trypsm (Sigma), alpha-chy-
motrypsm (E. Merck AG, Dannstadt, West Germany), pronase E 
(Merck), or 0.2% pepsin (Umversity Pham1acy, Hel;mki, Finland) 
at +2o·c for 2 min. The pepsin solunon al~o contained 0.01 N 
HCI. Paraffin sections fixed in Boum were covered with drops of 
Figure 1. Cryostat section fixed in Jcetone anJ \t.unc.'J w1th C1stron rabb1r 
beta anmcrum (02-1100). Intense staming for IL-l hera IS associated wnh 
kcrannocyte membranes. The dermal pole of ba~al cells rcmarn unstamcd. 
Magrulicatlon X 1000. 
Figure 2. A) Boum-fixed paraffin secnon stained with G MoAb hera 8. lnrracellular ;wnmg of kcrarmocytes for Il-l hera. Addmonally. there •s poSitive 
stainmg m stratum corneum. Magnification X400. B) Parallel section to A . G MoAb beta 8 wa; prcab~orhed w1th cxccss1ve riL-l prior to immunostammg. 
Magmficatlon X 400. 
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Figure J. Bomn-fixed paraffin ~cction stained with Cistron rahb1t hera 
anti~crum (02- I 1 00). Intense membrane-associated IL-1 i~ ~cen in most 
kerarinocytcs with lc~s Intense cytosolac staimng. Magnification X 400. 
Figure 4. Paraformaldehyde-fixed cyrospin preparation stained with Cl~­
tron rabb1t I L- 1 beta antl~erurn (02-11 00). All cells ~how borh cyto;olac and 
rnc-mhranc--as;ociatcd staining. Magnification X 1000. 
IL- l IN NORMAL EPIDERMAL CELLS 33 
Figure 5. Paraforrnaldehyde-fixcd cytospm preparation of human kcrari-
nocytcs stamcd w1th C1stron MoAb to IL- l beta (02-1025). There IS an 
inverse relationship between cell si7c and swnmg intcmity for cytosol1c 
11.-1. Some cells also show membrane-associated staanmg. Magmficmon 
X 1000. 
Figure 6. Paraformadehydc-fixcd cytOspan preparation of human kerauno-
cyu:s sramed with sheep $76 antiserum to ll- I alpha. Magmficarion X 1000. 
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Table I. Ann-ILl Anubodies and Antisera Used 
for Immunohistochemistry 
Amsbody Spectt's/ 
lmmunoperoxidase lsotype Source Dslutson Method 
Antt-IL-I beta 
Cisrron r~bbic 
02- 1100 Rabhst Ci~cron 1:50-1·200 ABC 
Csscron MoAb 
02-1025 Mouse lgM Csstron 1:36 ABC 
G MoAb 7 Mouse lgG2a Glaxo 1:350 AHC 
G MoAb 8 Mouse lgG2a Glaxo 1:350 ABC 
Sheep S77 
Ants-IL-l alpha 
Ci~rron rabbsc 
Sheep Glaxo 1:50 PAP 
02-11 50 Rabhsc Cisrron 1:50 ABC 
Sheep S76 Sheep Glaxo 1:50 PAP 
Goat G203 Goat Glaxo 1:50 PAP 
0.02% trypsm, alpha-chymotrypsin, pronase E, or 0.1 o/o pepsm and 
incubated at +37"C for 30 mm. 
Antibodies Polyclonal and monoclonal annbodies (MoAb) to 
human recombinant IL-l (riL-l) were purchased from Cistron 
T echnology (Pme Brook, NJ) or obtained as donations from Glaxo, 
Institute for Molecular Biology (Geneva, Switzerland) (Table I). 
Anti-Leu 3a (Becton Dickinson, Mountain View, CA), OKT6 
(Ortho Diagnostic Systems, Raritan, NJ), and a polyclonal rabbst 
antiserum to r!L-6 (Janssen Biochamica, Beerse, Belgium) were 
used as contro ls. Bullous pemphigoid (BP) antibody containing 
serum was collected from a pauent with BP and high antibody 
concentration. The avidin-biotin-complexes (ABC) (Vectastain 
ABC kit, rabbit IgG PK-4001 and mouse IgG PK-4002, Vector 
Laboratories Inc., Burlingame, CA), peroxidase-goat-anti-peroxt-
da~e (PAP goat) complexes (B 157), rabbit immunoglobulins to 
sheep immunoglobulins (Z l38) and rabbit immunoglobultns to 
goat immunoglobulms (Z228), all from Dakopatts, Copenhagen, 
Denmark, were used for ammunoperoxidase staining. An alkaline 
phosphatase-anu-alkalme phosphatase (APAAP)/PAP-double 
seaming ktt for mouse and rabbit antibodies {K0665), a fluorescein 
isothiocyanatc (FITC) conjugated rabbit antihuman IgA, IgG, l gM, 
kappa, lambda anttserum (F200), a FITC conjugated swine antirab-
bit antiserum {F 205), and normal rabbit serum (X902) were pur-
chased from Dakopatts. 
lmmunoperoxidase Staining According to ABC and PAP 
seaming methods, the sections were incubated with the respective 
antibodies for 30 min to 3 hat room temperature. Finally, the sec-
tions were incubated in the dark with 0.025% 3.3-diaminobenzi-
dinc tctrahydrochloride (DAB, Sigma) and 0.003% H20 2 in PBS, 
countcrstaincd with hematoxy lin, dehydrated in a gradc.-d alcohol 
series, cleared in xylene and mounted in Permount (Fisher Scien-
tific, Fair Lawn, NJ). 
Double staining for BP antigen and IL-l was performed usmg a 
FITC-peroxidase double-staining method, modified from pub-
lished methods [ 15, 16). The ABC-immunoperoxidase staining was 
performed as described above using a monoclonal IL- l beta-anti-
body G MoAb 8 (Table I). After immunoperoxidase seaming for 
IL-l, the sl ides were incubated with human BP antiserum diluted 
1 : 10 in PBS for 1 h, washed in PBS, and incubated with 5% normal 
rabbtt serum for 10 mm and FITC-rabbit-anti-human ammuno-
globuhns at a dilution of 1 : 30 for 30 min. After washes in PBS, the 
slides were mounted in Bacto FA mounting Fluid (Difco Laborato-
ries, Detro it, MI). 
Controls The following controls o f immunostaining were per-
formed. a) The primary anti-ILl antibody was replaced by PBS, a 
non-relevant monoclonal antibody or normal rabbit serum. b) Tis-
sue sections were stained for endogenous peroxidase activity with-
om antibody treatment. c) Exogenous riL-l beta (01-1500, Cistron) 
or purified human monocyte ILl (niL-1) of pi 7 (01-1200, Cistron) 
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was added to primary antibody dilutions at + 4"C to +20"C from 
30 min to 12 h prior to immunostaimng. The dilutions of antisera 
varied from 1 : 10 to 1 :50 and the diluttons of IL- l from 1 : 500 to 
undiluted. d) Two affinity chromatography columns were used for 
absorptton controls. One was prepared wtth 400 ,ul of riL-l beta 
(Cisrron) and 600 ,ul of niL-1 coupled 111 1.5 ml of CNBr-activated 
Sepharose 4B gel (Pharmacta, Uppsala, Sweden) following the 
manufacturer's instructions. The other con tamed 1 ml of 0.1 o/o bo-
vme serum albumin (BSA, 96-98% pure, S1gma) mstead of lL-1. 
One rntlliltter of Cistron MoAb dilution {I: 400) was applied on 
each column and preabsorbed twtce for 20 man at + 20"C prior to 
immunostaining. c) As the controls described in c and d failed to 
aholtsh unmunosraming of the keratinocytes, the following con-
trols were performed: 1 mg of riL-l beta (Glaxo) was added to 
100 ,ul of trcsyl-activated Sepharose 4A gel (Pharmacia). 500 ~tl of 
pa!L-1 beta (Cistron) diluted to 1 :200 in PBS was absorbed in the 
gel at+ 37"C for 1 h following incubation at +4 •c overnight and 
agam at+ 37•c for 1 h under agitation. For control of the proce-
dure, diluted antibody was incubated without riL-l and agarose. 
The absorbed and the non-absorbed anttbodtcs were centrifuged at 
10,000 X g for 30 min at +4"C prior to immunoperoxidase stain-
mg. Monoclonal anttbodies to IL-l beta G MoAb 8 were absorbed 
smularly except that they were diluted in Tris-buffered saline (TBS) 
containing 3% BSA and 0.5% Nonidet P40 (LKB-Produkter, 
Bromma, Sweden) and that 100 ,ug of riL-l beta was used. 
Flow Cytofluorography Isolated epidermal cells were sus-
pended without fixation m Dulbccco's PBS containing 2% normal 
swine serum at+ 4 • c. 5 X 105 cells were mcubated in 100 ,ul of the 
primary antiserum dilution for 30 mm on ice, washed twice by 
centrifugation at +4"C, incubated in FITC-swme-anrirabbit anti-
senun ( l: 50), and washed twice again. PBS contaming 2% normal 
swine serum was used for the antibody dilutions and washings. The 
viabtl aty was over 96% as j udged by trypan blue staining. The cells 
were analyzed by flow cytofluorography (FACScan, Becton Dick-
in~on, Mountain View, C A). A populatton of2500 cells was gated 
into two subpopulations according to cell size to exclude possible 
cell debri~ and clumped celh. Cutoff channel was fixed using cells 
seamed without pnmary anubody as negative controls. 
RESULTS 
Effect of Tissue Processing on IL-1 lmmuooreactivity 
Table II shows the effect of processmg skin tissue samples and 
isolated epidermal cells on IL-l beta and alpha immunoreactivities. 
A stmilar staimng pattern for IL-l was seen with tissues obtained 
from vanous body sites, including the palms of the hands. 
Tissue Sections: IL-l Beta The most consistent intercellular 
IL-l beta immunoreactivity was seen in unfixed, acetone or ether-
fixed cryostat sections (Fig 1 ); cytosolic IL-l beta immunoreactivity 
was also consistently seen. With aldehyde-based fixatives, IL-l im-
munoreactivity was mainly cytosolic in both cryostat and paraffin 
sections. In paraffin sections fixed m Boum 's fluid, which contains 
formaldehyde and protein precipitating acids, cytosolie IL-l beta 
immunoreactivity was detected with all the antibodies used, e.g., G 
MoAb 8 (Fig 2). However, intercellular IL-l immunoreactivity was 
seen with some antibodies. This intercellular IL- l immunoreactiv-
Ity was especially intense with Cistron rabbit beta antiserum 
(02-1100) (Fig 3). The effects of tissue processing were most promi-
nent with two antibodies: a) Cistron MoAb (02-1025), which in 
cryostat sections showed a staining pattern similar to C istron rabbit 
antiserum {02-11 00), but in paraffin sections fixed in Bouin's fluid 
showed only cytosol ic but no intercellular immunoreactivity; b) G 
MoAb 8, which in cryostat sections showed immunoreactivity only 
m basal cells, but in paraffin sections showed immunoreactivity in 
al l epidermal cell layers (Fig 2). 
IL-l Alpha Cytosol ic IL-l alpha immunoreactivity was seen 
with all fixatives used. The most intense cytosolic IL-l alpha immu-
noreactivity was seen in the basal ce ll layer with all three IL-l alpha 
antisera used; a less intense staining was seen in all other epidermal 
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cell layers. Intercellular IL-1 alpha immunoreactivity was most in-
tense in granular cell layer with sheep S76 anriserum; however, 
with the rwo other antisera used it was most intense in the basal cell 
layer. In Bouin's fluid-fixed paraffin sections, mrercellular IL- l 
alpha immunoreactivity was seen in only a few cells and with only 
one annserum, i.e. , goat G203. 
Isolated Epidermal Cells Tables II and Ill show the effects of 
sample processing on IL- l immunoreactivity. The use of 1solated 
cells showed that the intercellular IL-l immunoreactivity observed 
in tissue sections was associated with keratinocyte cell membranes. 
A good morphology combined with preservation of both mem-
brane-associated and eyrosolic IL-l Immunoreactivities was seen in 
cells fixed in paraformaldehyde (Figs 4 -6). Compared to parafor-
maldehyde fixation, ether or acetone fixation enhanced membrane-
associated IL-1 beta immunoreactivity (Fig 7}, whereas IL- 1 alpha 
immunoreactivity was diminished. 
The distribution of IL-1 immunoreactivities with the various 
antibodies was similar in tissue sections and isolated keratinocytes. 
In cytospin preparations, some antibodies, e.g., G MoAb beta 8, 
detected intense cytosolic IL-l beta immunoreactivity in only the 
smallest keratinocytes; additionaHy, a less intense staining of larger 
keratinocytes was seen (Ftg 8}. Double staining with G MoAb beta 8 
and BP antiserum showed that intense IL-1 immunoreactivity was 
in fact present only in basal cells (Fig 9). With some antibodies, e.g., 
Cistron rabbit beta antiserum (02-11 00), all keratinocytes showed 
intense Immunoreactivity to IL-l (Fig 4). This staining was cyto-
solic but showed a peripheral ring compatible with membrane-asso-
ciated immunoreactivity. 
The results obtained with other antibodjes (Table Ill} were in 
concordance with the findings on tissue sections, except that para-
formaldehyde did not mask membrane-associated IL-1 immunore-
activity in isolated epidermal cells (Table II}. 
The results obtained by flow cytofluorography are shown in Fig 
10. One half (49%) of the small epidermal cells and 14% of the 
larger ep1dermal cells stained with Cistron rabbit beta .lnmerurn 
(02-11 00) showed intense fluorescence. In contrast, no such in-
crease in fluorescence was seen with the IL-l alpha antiserum used 
(02-1150); 0% of the small cells and 6o/o of the larger cells showed 
membrane-associated fluorescence. 
Enzymatic Treatment of Tissues and Cells EnzymatiC treat-
ment either diminished or enhanced IL-l immunoreactivity in nor-
mal human epidermis, depending on sample processing and the 
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antibody used . In most cases, enzymatic treatment diminished the 
IL- l immunoreactivity. T able IV shows that pepsin treatment of 
unfixed isolated keratinocytes enhanced the cytosolic IL-l beta im-
munoreacnvity for G MoAb 8; after this treatment, membrane-as-
sociated immunoreactivity of intermediate size cells was also de-
tected. Chymotrypsin treatment of paraffin sections enhanced the 
IL-l immunoreacrivity in the granular cell layer. Enzymatic treat-
ment of paraffin sections with the four proteases used had no effect 
on IL-l beta immunoreactivity to Cistron MoAb in the granular cell 
layer, although immunoreactivity of all other cell layers was clearly 
dimjnished. A similar phenomenon of all proteases, except pepsin, 
was seen with G MoAb 7. No such variations in the proteolytic 
effects 111 various cell layers were seen with IL-l alpha antibodies. 
Specificity of IL-l Staining When normal rabbit serum was 
used instead o f the primary polyclonal anti-IL-l antisera, no mem-
brane-associated staining was found. However, some cytosolic 
staining of epidermal cells was seen. When the primary antibody 
was omitted, no epidermal immunoreactivity was detected. The 
addition of either riL-l beta or niL-1 to the diluted primary anti-
body, or use of primary antibodies preabsorbed by IL-1 or BSA 
affinity columns prior to the irnmunostajning, did not alter the 
staining pattern. In contrast, preabsorption of both Cistron rabbit 
beta antiserum (02-1100) and G MoAb beta 8 by excessive riL-l 
coupled to Sepharose beads abolished or greatly diminished the 
immunoreactivity of epidermal cells (Fig 2). 
In flow cytofluorography, a rabbit anti-serum to IL-6 was used as 
an additional negative control for membrane staining of small epi-
dermal cells. Only 2% of the cells were fluorescent (Fig 10). 
DISCUSSION 
Previous studies on immunohistochemical localization of iL-1 spe-
cies in human epidermis have yielded discrepant results. Tron et al 
[ 13] used a monoclo nal antibody to IL-1 beta, which showed no 
intracellular and only faint cytoplasmic immunoreactivity in nor-
mal human ep1dermis. No immunoreactivity of stratum corneum 
was mentioned. Oxholm et al (11] used a polyclonal antiserum 
which showed laminar IL- l immunoreactivity of stratum corneum 
in normal human skin. Additionally, with the exception of basal 
cells, many keratinocytes showed intercellular staining. Intracellu-
lar staining for IL-1 was seen only with low dilutions of the anti-
serum. Didierjean et al (12] used a panel of monoclonal and poly-
clonal antibodies to both IL-l alpha and beta. IL-l beta 
Table II. Effect ofTissuc Proce~smg on IL-l Beta and Alpha Immunoreactivtties in Normal Human Epidermis 
F1 xanvc 
None 
Acetone 
Ether 
Parafonnaldehydc 
Glutaraldehyde 
Fonnaldchyde 
Douin's flUid 
• Gr.aded from- to+++. 
'Or mtercellular. 
Cell or Tissu~: Sample 
EC• 
Cryostat 
EC 
Cryostat 
EC 
Cryostat 
EC 
Cryostat 
Paraffin 
Cryostat 
Paraffin 
Cryostat 
Paraffin 
Cryostat 
Paraffin 
' l sol~ted suctaon bli.ncr-denvrd ep1dermal cells. 
Stammg lnt~:nmy: Pnnury Antibody, Cisrron Rabbit 
Deta 02-1100 Alpha 02-1025 
---
MC'mbrane-Assoclat<'d1 Cytosohc Membran~:-Assoctated1 Cytosohc 
----
+++ ++ ++ ++ 
+++ + + ++ 
+++ ++ ++ ++ 
+++ + + ++ 
+++ ++ ++ ++ 
+++ (+) ND 
+++ ++ ++ ++ 
++ (+) ++ 
++ NO 
+++ +++ 
+ + NO (+) (+) 
++ NO 
NO 
+++ + ++ 
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Figure 7. Same a~ Fig 5 except w1th rd1cr fixauon. Cyto~ol ic scammg for 
IL-l beta~~ mmlar to that 111 Fig 5; however, with this fixation an additional 
1nten~e mcmbrane-a~~oCiated ~tammg 1s seen 111 most kcraunocytcs. Magru-
ficatlon X I 000. 
immunoreactivity was consistently detected at the level of ~tratum 
granulosum, where I L-1 alpha Immunoreactivity, although less 
consistentl y, also localized. Several monoclortal antibodies to IL-1 
beta reacted intensively and specifically with epidermal basal cells. 
No IL- l Immunoreactivity was detected in stratum corneum. In the 
present study, we detected IL- t immunoreactivity at all the sires 
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Figure 8. Acetone-fixed cytospm preparation of human keratinocytes 
stamed for IL-l beta w1th G MoAb beta 8. Intense cytosolte and membranc-
assocrarcd stamtng of the small kcratinocytcs and less mtense seaming of the 
larger cells. Magnrficarion X 1000. 
described rn earl ier studies. However, additional Sites with specific 
JL- 1 immunoreactivity were also observed: we found both mcm-
hranou\ and cyrosolic IL- l immunoreactivity in all epidermal cell 
layers rncluding stratum corneum. There may be several explana-
tions for the discrepancies between the various studies. 
a) The or~~irr of the sample: The hypothesis could be put forward 
that IL- 1rmmunoreactivity ts not uniformly expressed in all parts of 
the body due, for instance, to sun exposure and/or other factors. 
Figure 9. Accrone-lixrd cyrospin prcparanon of human keratinocytes double-stained with G MoAb beta 8 and BP annserum. A) Ustng an immunoperoxida:;e 
tcchruque, three small kerattnocytes stain with G MoAb beta 8; larger cells show only diffuse, weak staining. B) The same cells wh1ch sramcd intensely wirh G 
MoAb beta 8 ~how patchy immunoAuorescence staining w1th BP antigen, mdicaring rhat they arc basal cells. Magmficaoon X400. 
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Table ill. Effect of Ftxation on IL-l Immunoreactiv1ry m Isolated Human Kerattnocytes 
Ant1body 
Anri-IL-1 beta 
Cimon rabbit 02-1 I 00 
C1stron MoAb 02-1025 
G MoAb7 
G MoAb8 
Shtep S77 
Anu-IL-1 alpha 
C1mon r:~bbu 02-1 ISO 
Sheep $76 
Goat G203 
• Grade-d from- to+++. 
--
--
No Fixanon 
+++/+++ 
+++/+ 
++/+ 
++/+ 
ND 
+++/+++ 
ND 
ND 
Previous observarions [ 12] as well as our present findings show that 
this is nor so because samples from different body sites showed a 
similar immunoreactiv1ry pattern . 
b) Tlat sperificicy of the stainin,r Tron eta! (13] abolished the stain-
ing tn cutaneous T-cell lymphoma skin by the addition of exoge-
nous riL- l in primary antibody dilution. Ox holm et al [ 11] could 
not abolish IL-l staining by the addition of monocytic IL-1 or riL-l 
beta. Didierjean et al abolished IL-l staining by absorption of anti-
IL- l antibodies with recombmant IL-l beta coupled to Sepharose 
beads (t2J. In the present study, we failed to abolish IL-l beta immu-
noreacttviry by usmg riL-l beta as described by Tron et al [13]. 
However, by preabsorptton of primary antibodies with riL-l beta 
coupled to Sepharose beads, both membrane-associated and cyto-
solic st.'lining was abolished from all cell layers, including stratum 
corneum. 
c) Antibody 11sed and fisSile processing: Tron et al (13] used unfixed 
cryostat sections for fL-1 immunohistochemistry, whereas Ox holm 
ct al (II] used acetone-fixed cryostat sections followed by hydrogen 
peroxide treatment. DidierJCan ct a! [ 12) tested various aldehyde 
based cross-linking fixattves and found no significant differences 
between the use of d1ffercnt Immunohistochemical staining 
methods. In all these stud1es, fL-1 immunoreactiviry patterns were 
restricted to certain cells or epidermal cell layers. W e suggest that 
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Figure 10. Flow cytofluoromcmc histograms of small human ep1dermal 
cell\. The absctssa denotes fluorescence tntcnstry on a loganthmtc scale and 
the onhnatc denotes cell frequency on a lincar scale. The pos1tion of the 
cutoff channel {l•trllca//;,,r) was fiud w1th a ncgattvc control, an wh1ch the 
pnmary antiSerum was omitted (A) A rabbit antiscmm to IL-6 was used as 
an additmnal ncgauvc control (B) Small epidermal cells sta111cd w1th a 
rabh1t anmenam to IL- l alpha (02- 1 I 50) show no fluorescence (C) . In 
contra~t. 49% of the cells stained with a rabbit anttsc:rum to IL beta 
(02-11 00) show membrane-assoCiated fluorescence (D) . 
--- -
Staanang lmc:nmy• (membrane-assoctatedj cytosohc) 
Paraformaldehydc Ether Acetone 
++/++ +++/++ +++/++ 
++/++ +++/(+) +++/(+) 
++j++ ++/+ ++/+ 
++/++ ++/+ ++/+ 
+++/++ ++/+ ND 
++/++ ++/++ ++/++ 
+++j+++ ++/++ NO 
+++/+++ ++/++ ND 
most if not all keratinocytes disrlay IL-1 bera and alpha immuno-
reactivities provided a panel o appropriate techniques are used. 
Such techniques include use of a) various fixatives at appropriate 
temperatures and fixarion times, b) both cryostat and paraffin sec-
tions, and isolated keratinocytes, and c) protease treatment of the 
samples prior to immunohistochemistry. By using these different 
approaches it is possible to avoid false positive or negative staining 
results due to: a) diffusion artifacts, b) destruction of the cpitopes 
(antigens} by the fixative, and c) masking of the epitope by cross-
linking fixatives. 
The use of isolated keratmocytes in the present study provided 
additional information on epidermal IL-1. First we confirmed that 
the intercellular immunoreactiviry observed in earlier studies 
[11 ,13] is membrane-associated. The membrane-associated IL-l 
immunoreactivity of the granular cell layer has already been con-
firmed by immunoelectron microscopic studies [ 12), but the present 
study suggests that the cross-linking fixatives required for sufficient 
morphology on electron microscopic levels may have masked anti-
gens or diminished membrane-associated fL-1 immunoreactiviry in 
other epidermal cell layers of tissue sections. We found that this 
docs not occur in morphologically well-preserved, paraformalde-
hyde-fixcd, isolated cells, which show intense membrane-asso-
ciated staining that can be seen at light microscopic leveL In tissue 
sections, paraformaldehyde could form intercellular cross-linkages 
thaL could mask membrane-associated IL- I. Our flow-cytofluoro-
metric studies provided further quantitative evidence of the mem-
brane-associated IL-l beta on human epidermal ce lls. Second we 
confirmed that the IL-1 beta immunoreactiviry at the basal cell layer 
for one monoclonal antibody (G MoAb 8} described earlier (12] 
corresponded to intense immunoreactivity in small isolated epider-
mal cells which also reacted with the BP anriscrum and hence 
proved to be basal cells. However, cytospin preparations clearly 
showed that this antibody also showed slight immunoreactivity 
with larger, BP-negative epidermal cells. This suggests that the 
epitope recognized with this particular antibody was present in low 
amounts in suprabasaJ cells or that only a minoriry of the epitopes 
present could be recognized due to masking by other cellular ele-
ments. This finding was further supported by the intense immuno-
reactiviry observed in Bouin-fixed paraffin sections, which showed 
a similarly intense immunoreactiviry throughout the epidermis. 
After protease treatment of tissue sections, the IL-1 beta immuno-
reactivlry of the granular cell layer was enhanced with some ann-
bodies used, whereas the IL-l beta immunoreactivities of other cell 
layers were clearly diminished. An earlier study has shown that 
trypsin treatment caused a release of a 23-kD form of IL-l from 
stimulated human monocytes [3]. Such trypsin treatment of para-
formaldehyde-fixed or unfixed activated human monocytes caused 
a rise m the I L-1 activiry of the plasma membrane and the cytosol; it 
was therefore suggested that these sites arc involved in the release of 
IL- l [17]. The precise cleavage sites of the IL-l beta precursor have 
been studied recently in an in vitro system. Trypsin digestion of 
human monocytes or myeloid cell lines resulted in tenfold and 
chymotrypsin digestion in an over 500-fold increase in IL-l activiry 
[18]. Inhibition of proteolysis by leupeprin, on the other hand, 
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Table IV. Effect of Enzymatic Treatment on IL-l Beta Immunoreactivity in Normal Human Epidermis for G MoAb 8 
Staming IntenSity" 
Stratum Basal or Small Cells 
Membrane· 
Sample Enzyme Assoctaud Cytosolic 
EC' None ++ + 
Tryp;in (+) (+) 
Pepsm ++ ++ 
Paraffin sectton' None + 
Trypsm 
Pepsin 
Pronase 
Chymotrypsm 
• Graded from - ro +++. 
1 bolared sucuon blisrer-denved eprdernul cells (unfixed). 
• Fixed m Bourn's flUid. 
+ (+) 
caused a reduced amount of detectable low-molecular-weight IL- l 
alpha from murine macrophages [19]. Although not proved, the 
proteolytic IL-l cleavage in human monocytes could exist in kerati-
nocytes. The diminished I L-1 Immunoreactivity in the basal and 
spinous cell layers of the epidermis, which we observed after pro-
tease treatment of paraffin sections, could be explained by cleaved 
and released lL-1, which had been rinsed off during the immuno-
staining procedures. It is also possible that during maturation of 
keratinocytes, IL-l might be differently localized and/or bound to 
cell structures, as suggested earlier [12], and that che IL-l in che 
granulous cell layer would therefore be resistant co protease treat-
ments. 
The present study suggests chat the immunohistochemical ap-
proach co IL-1 status in skin diseases should be considered with great 
caution. That both IL-1 alpha and beta immunoreactivities are iden-
tified by immunohistochemistry contrasts with the fact that IL-1 
alpha is che main form measured by immunoassays in epidermal 
ex trace (9.57 ± 2.28 ng/ mg protein), whereas IL-l beta is under che 
detection !.mit of 10 ng/ ml (20]. This is probably due to che fact 
that a part of the IL- l epidermal pool is noc recovered in epidermal 
extracts but still idennfied in tissue sections. 
The significance of membrane-associated lL-1 of epidermal cells 
remains to be established. In macrophages, membrane-associated 
IL-1 has been thought co be involved as an accessory signalm T -cell 
responsesJ4,21 ]. Accordingly, epidermal cell membrane-associated 
IL-1 coul be a factor for activation of intraepidermal T cells, e.g., 
after antigen challenge. 
We wish to thattk Dr. T1tomo Timotttll (Uttiversity ofHt/m,ki) for perform in.~ tlrt 
jlow-rytojluoroxraphic attnlym. 
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